Patients were satisfied or very satisfied with preservative-free latanoprost
In a real-world study* of 1872 patients who switched to preservative-free latanoprost ophthalmic solution 0.005% formulation and were treated with it for at least 3 months or were treatment-naive at the time of the study—
Review factors that impacted a
PRESERVATIVE-FREE SWTICH
The proportion of patients satisfied with preservative-free latanoprost ophthalmic solution 0.005% was similar among patients who had previously received preserved medication 95.3% (p<0.0001) and among those who were treatment-naive (97.3%).1
*Based on results from a multicenter, international, transverse, epidemiological survey conducted in routine private ophthalmology practices to assess level of satisfaction among preservative-free latanoprost-treated patients.1
Patients reported improved Satisfaction and Tolerability after switching to preservative-free latanoprost
Why switch to preservative-free latanoprost?
Patients’ evaluation of their tolerance to glaucoma treatment is key to assessing treatment efficacy1
There are many factors that can make an impact on patients who switch to preservative-free latanoprost ophthalmic solution 0.005%. The most common reason for switching to preservative-free latanoprost was local intolerance or lack of efficacy, according to 1872 patients surveyed during a routine clinical examination with their ophthalmologist.1
This real-world study of patients who switched to preservative-free latanoprost ophthalmic solution 0.005% formulation and were treated with it for at least 3 months at time of study found that patient satisfaction was significantly associated with1:
Patients appreciated how easy and convenient IYUZEH was to use
89.5% of patients (n=1276) found single-unit, preservative-free latanoprost to be easier than or as easy to use compared to their previous preserved treatment.1,*
*In a multicenter, international, transverse, epidemiological survey (n=1872).
Hear what your colleagues are saying about IYUZEH
Having the opportunity for IYUZEH and a preservative-free latanoprost for my patients is a game changer. This will afford my patients a more well-tolerated, more comfortable, and very effective treatment approach to their glaucoma disease. So, it’s gonna be great for my patients and my practice.
Michael Chaglasian, OD, FAAO
Dr. Chaglasian is a paid consultant of Thea Pharma Inc.
Visit our Video Library to Hear Why Eye Care Professionals are Choosing IYUZEH
Things your patients may not say, but could be thinking
Isaac has been using eye drops for a long time. He has not been satisfied with his current IOP-lowering drops. Then he found out about IYUZEH™ (latanoprost ophthalmic solution) 0.005%, the first and only preservative-free latanoprost, and asked his eye care professional.
With IYUZEH, Isaac looks forward to a treatment experience that he can stick with long-term.
†Patient portrayal. Not an actual patient.
